Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.08 (-7.56%)
Close on Nov 13, 2026Market cap $638.94KP/E –Yield –
Decoy Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Decoy Therapeutics's gross margin for the twelve months ending Jun 30, 2019 was 88.5%. For fiscal 2018 it was 77.9%, against 60.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 77.9% | +17.7 |
| FY2017 | Dec 31, 2017 | 60.3% | +25.8 |
| FY2016 | Dec 31, 2016 | 34.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2019 | Jun 30, 2019 | 96.0% | +69.3 |
| Q1 FY2019 | Mar 31, 2019 | 92.8% | +39.8 |
| Q4 FY2018 | Dec 31, 2018 | 54.0% | +1.2 |
| Q3 FY2018 | Sep 30, 2018 | 80.4% | +16.4 |
| Q2 FY2018 | Jun 30, 2018 | 26.7% | −30.0 |
| Q1 FY2018 | Mar 31, 2018 | 53.0% | −14.4 |
| Q4 FY2017 | Dec 31, 2017 | 52.9% | −2.4 |
| Q3 FY2017 | Sep 30, 2017 | 64.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 56.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 67.4% | – |
| Q4 FY2016 | Dec 31, 2016 | 55.3% | – |
See a number that looks wrong?